Projects per year
Personal profile
Education
- 國防醫學院醫學系學士
Research Interests
- 癌症臨床試驗及抗癌藥物
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Jang-Yang Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 6 Finished
-
-
剖析干擾素相關基因特徵在口腔腫瘤微環境之角色: 治療策略與生物標記開發-探討粒線體DNA損傷所誘導干擾素路徑在口腔癌發炎腫瘤微環境之角色：診斷標記與機制研究(2/3)
Chang, J.-Y. (PI)
19-08-01 → 20-07-31
Project: Research project
-
-
探討cathepsin S在EGFR訊息傳導之分子機轉調控研究─提供改善cathepsin S抗癌藥物之潛力發展
Chang, J.-Y. (PI)
16-08-01 → 17-07-31
Project: Research project
-
探討cathepsin S在EGFR訊息傳導之分子機轉調控研究─提供改善cathepsin S抗癌藥物之潛力發展
Chang, J.-Y. (PI)
15-08-01 → 16-07-31
Project: Research project
-
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models
Tang, Y. C., Ou, J. J., Hsu, S. C., Huang, C. H., Lin, L. M., Chang, H. H., Wang, Y. H., Huang, Z. T., Sun, M., Liu, K. J., Hung, Y. M., Lai, C. Y., Shih, C., Chen, C. T., Chang, J. Y., Hsieh, H. P., Jiaang, W. T. & Kuo, C. C., 2025 Jan, In: Pharmacological Research. 211, 107556.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Cathepsin S regulates antitumor immunity through autophagic degradation of PD-L1 in colorectal cancer cells
Taheri Baghmisheh, S., Chen, C. H., Yeh, Y. M., Lin, P. C., Chen, P.-C., Chan, R. H., Kang, J.-W., Lee, C. T., Tsai, H. J., Fang, Y. C., Cheung, C. H. A., Chang, K. Y., Chang, J. Y. & Chen, S. H., 2025 Sept, In: Cancer Immunology, Immunotherapy. 74, 9, 287.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 Expression
Peng, H. Y., Chang, C. W., Wu, P. H., Li, L. J., Lin, Y. L., Hsiao, M., Chang, J. Y., Chang, P. M. H., Lee, H. L. & Chang, W. M., 2025 Feb, In: International journal of molecular sciences. 26, 3, 1077.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Synthesis, Anticancer Evaluation and Structure–Activity Relationship of Taiwanin a Derivatives
Chang, C. I., Kuo, C. C., Wein, Y. S., Chao, C. Y., Chen, Y. C., Chang, J. Y. & Kuo, Y. H., 2025 Jan, In: Chemistry of Natural Compounds. 61, 1, p. 11-18 8 p.Research output: Contribution to journal › Article › peer-review
-
The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses
Peng, H. Y., Huang, Y. L., Wu, P. H., Li, L. J., Peng, B. Y., Wu, C. Y., Lin, Y. L., Hsiao, M., Chang, J. Y., Mu-Hsin Chang, P., Lee, H. L. & Chang, W. M., 2025 Dec, In: Cancer Cell International. 25, 1, 114.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)